Skip to main content
. 2021 Nov 24;7(1):75–84. doi: 10.1002/epi4.12559

TABLE 2.

Perioperative characteristics

Summary Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10 Case 11
MRgLITT procedure Complete CC Posterior 1/3 CC Ant 2/3 CC Complete CC Complete CC Complete CC Ant 2/3 CC Complete CC Genu & splenium Posterior 1/3 CC Residual splenium w/ RNS placement
Prior surgery Microsurgical ant 2/3 CC; VNS placement Microsurgical CC; VNS placement Microsurgical ant 2/3 CC; VNS placement (Case 10)
VNS, n (%) 6 (75) Yes Yes Yes Yes Yes Yes Yes Yes Yes
LITT trajectories, M (SD) 3 3 2 2 3 4 3 3 2 4 2 1
Laser on time (min), M (SD) 12.4 ± 7 10.9 5.6 20.8 8.3 24.4 13.6 10.4 3.72 14.95 4.8 2.57
Surgery length (h), M (SD) 5.8 ± 1.7 5.6 2.9 6.9 6.8 8.1 3.9 6.4 7.13 9.03 5.8 7.18
Blood loss (mL), M 6 ± 5 5 5 10 10 15 5 0 0 5 0 50
LOS ICU (d), median (IQR) 1 (1‐2) 2 1 2 1 5 2 1 1 1 1 3
LOS floor (d), median (IQR) 1 (0‐1) 1 0 1 1 1 1 0 0 1 1 0
Total LOS (d), median (IQR) 2 (1‐3) 3 1 3 2 6 3 1 1 2 2 3
Discharge home, n (%) 6 (82) Rehab Home Home Home Rehab Home Home Home Home Home Home
Postoperative transient functional change, n (%) 4 (36) Left‐sided weakness; back to baseline after rehab None None None Worsened truncal ataxia; back to baseline after rehab Weakness, difficulty ambulating; baseline at discharge Non‐verbal 6 d post‐op, self‐resolved None None None None
Permanent neurologic deficit 0 None None None None None None None None None None None

Abbreviations: CC, corpus callosotomy; VNS, vagal nerve stimulatory; RNS, responsive nerve stimulator.